In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification.
Gato E, Guijarro-Sánchez P, Alonso-García I, Pedraza-Merino R, Conde A, Lence E, Rumbo-Feal S, Peña-Escolano A, Lasarte-Monterrubio C, Blanco-Martín T, Fernández-González A, Fernández-López MDC, Maceiras R, Martínez-Guitián M, Vázquez-Ucha JC, Martínez-Martínez L, González-Bello C, Arca-Suárez J, Beceiro A, Bou G.
Gato E, et al. Among authors: fernandez gonzalez a.
Int J Antimicrob Agents. 2023 Oct;62(4):106935. doi: 10.1016/j.ijantimicag.2023.106935. Epub 2023 Aug 3.
Int J Antimicrob Agents. 2023.
PMID: 37541530